Resultados: 28

    Guideline No 428: management of dichorionic twin pregnancies

    J. obstet. gynaecol. Can; 44 (7), 2022
    To review evidence-based recommendations for the management of dichorionic twin pregnancies. Pregnant women with a dichorionic twin pregnancy. Implementation of the recommendations in this guideline may improve the management of twin pregnancies and reduce neonatal and maternal morbidity and mortality. P...

    Guideline No 427: folic acid and multivitamin supplementation for prevention of folic acid–sensitive congenital anomalies

    J. obstet. gynaecol. Can; 44 (6), 2022
    To provide updated guidance on pre-conception folic acid and multivitamin supplementation for primary and secondary (recurrence) prevention of neural tube defects and other folate-sensitive congenital anomalies. Women aged 12-45 years who could become pregnant should be aware of the risk of serious birth...

    Guideline No. 426: Hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management

    J. obstet. gynaecol. Can; 44 (5), 2022
    This guideline was developed by maternity care providers from obstetrics and internal medicine. It reviews the diagnosis, evaluation, and management of the hypertensive disorders of pregnancy (HDPs), the prediction and prevention of preeclampsia, and the postpartum care of women with a previous HDP. Impl...

    Guideline No. 420: cytomegalovirus Infection in Pregnancy

    J. obstet. gynaecol. Can; 43 (7), 2021
    To provide an update on current recommendations for cytomegalovirus (CMV) infection during pregnancy. The objectives of this guideline are: To improve perinatal care providers’ awareness of the consequences of maternal CMV infection for the fetus and the infant; To emphasize the importance of educating...

    The Use of Dexamethasone in Patients with High-Grade Gliomas

    Patients with primary brain tumours often develop vasogenic edema and increased intracranial pressure. Corticosteroid therapy improves this in most patients, generally within 48 hours. As such, corticosteroid therapy is sometimes a necessary prerequisite to embarking on chemotherapy and radiotherapy foll...

    Guideline No. 416: labour, delivery, and postpartum care for people with physical disabilities

    J. obstet. gynaecol. Can; 43 (6), 2021
    To describe evidence-based practice for managing the labour, delivery, and postpartum care of people with physical disabilities in Canada. This guideline addresses the needs of people with physical disabilities, with a focus on conditions that affect strength and mobility, as well as those that affect ne...

    Guideline No. 414: management of pregnancy of unknown location and tubal and nontubal ectopic pregnancies

    J. obstet. gynaecol. Can; 43 (5), 2021
    To provide an evidence-based algorithm to guide the diagnosis and management of pregnancy of unknown location and tubal and nontubal ectopic pregnancy. All patients of reproductive age. The implementation of this guideline aims to benefit patients with positive β-human chorionic gonadotropin results and...

    Guideline No. 417: prevention of venous thromboembolic disease in gynaecological surgery [Pré-print]

    The primary objective of this clinical practice guideline is to provide gynaecologists with an algorithm and evidence to guide the use of thromboprophylaxis in gynaecological surgery. All patients undergoing gynaecological surgery for benign or malignant indications. The implementation of this guideline ...

    Guideline No. 410: prevention, screening, diagnosis, and pregnancy Management for fetal neural tube defects

    J. obstet. gynaecol. Can; 43 (1), 2021
    This revised guideline is intended to provide an update on the genetic aspects, prevention, screening, diagnosis, and management of fetal neural tube defects. Target population: Women who are pregnant or may become pregnant. Neural tube defect screening should be offered to all pregnant women. For preven...

    Guideline No. 408: management of gestational trophoblastic diseases

    J. obstet. gynaecol. Can; 43 (1), 2021
    This guideline reviews the clinical evaluation and management of gestational trophoblastic diseases, including surgical and medical management of benign, premalignant, and malignant entities. The objective of this guideline is to assist health care providers in promptly diagnosing gestational trophoblast...